Miller Richard A Md Insider Trades

Insider Trading History

Track insider trading activity for Miller Richard A Md. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $13.9M 1,195,035 shares
Last Trade
May 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.2k 1,932 shares
$12.01
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $13.8M 1,193,103 shares
Last Trade
May 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$60.3k 5,000 shares
$12.05
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $11.6M 1,000,000 shares
Last Trade
Dec 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.81M 1,000,000 shares
$8.81
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $0 0 shares
Last Trade
May 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.96M 559,073 shares
$3.50
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $13.2M 1,136,707 shares
Last Trade
May 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.96M 559,073 shares
$3.50
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $8.7M 750,000 shares
Last Trade
Dec 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.74M 750,000 shares
$4.99
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $13.8M 1,188,103 shares
Last Trade
May 10, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$628k 302,016 shares
$2.08
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $6.7M 577,634 shares
Last Trade
May 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.17M 1,136,707 shares
$1.91
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $5.8M 500,000 shares
Last Trade
Dec 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$820k 500,000 shares
$1.64
$11.60
Bolt Biotherapeutics
Bolt Biotherapeutics BOLT
Director
Holding Value $119k 25,000 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.8k 25,000 shares
$1.63
$4.75
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
Holding Value $9.28M 800,000 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$728k 800,000 shares
$0.91
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $17.3M 1,490,119 shares
Last Trade
Dec 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.8k 10,000 shares
$0.78
$11.60
Bolt Biotherapeutics
Bolt Biotherapeutics BOLT
Director
Holding Value $119k 25,000 shares
Last Trade
Dec 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34k 25,000 shares
$1.36
$4.75
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $17.2M 1,480,119 shares
Last Trade
Dec 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$37k 50,000 shares
$0.74
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $16.2M 1,394,405 shares
Last Trade
Sep 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19k 25,000 shares
$0.76
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $15.9M 1,369,405 shares
Last Trade
Sep 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.1k 5,000 shares
$0.82
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $15.8M 1,361,705 shares
Last Trade
Sep 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.96k 12,300 shares
$0.81
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $15.8M 1,364,405 shares
Last Trade
Sep 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.21k 2,700 shares
$0.82
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $3.71M 320,000 shares
Last Trade
Aug 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 320,000 shares
$0.96
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
President And CEO
Holding Value $15.7M 1,349,405 shares
Last Trade
Jun 24, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.35k 5,000 shares
$0.87
$11.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up